Zilucoplan for Severe gMG Exacerbations

Abroad (travel likely)RecruitingPHASE3

Conditions

Generalized Myasthenia Gravis (gMG)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

The Ohio State University, Columbus, Ohio, United States
Contact: Study coordinator (Karim Kheniser, CCRP) · Karim.Kheniser@osumc.edu · 614-293-6953
Contact: Study coordinator (Julie Agriesti, MACPR, CCRC) · Julie.Agriesti@osumc.edu · 614-293-4098
Contact: Principal Investigator (Miriam Freimer, MD)

Study leads

Miriam Freimer, MD
Principal Investigator
Ohio State University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study to Evaluate Subcutaneous Zilucoplan in Pediatric Participants With Generalized Myasthenia Gravis

Generalized Myasthenia Gravis

Abroad (travel likely)RecruitingPHASE2, PHASE3

Chicago, United States · Denton, United States

Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)

Generalized Myasthenia Gravis

Abroad (travel likely)RecruitingPHASE3

Phoenix, United States · Longmont, United States

A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)

Generalized Myasthenia Gravis

Abroad (travel likely)RecruitingPHASE3

Scottsdale, United States · Los Angeles, United States

A Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib Versus Placebo in Adult Patients With Generalized Myasthenia Gravis

Generalized Myasthenia Gravis

Abroad (travel likely)RecruitingPHASE3

Phoenix, United States · Scottsdale, United States